Sanofi, 10% Owner at Inozyme Pharma, Inc. (INZY), bought 520,125 shares at $16.00 ($1.3M) on 2020-07-28, disclosed to the SEC on 2020-07-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 438,875 | $0 | 0.0% |
| 2 | $16.00 | 81,250 | $1.3M | 100.0% |
| Total | $2.50 avg | 520,125 | $1.3M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |
| REGN | SELL | 2020-05-29 | $2.4B | — | Filing → |